<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363016">
  <stage>Registered</stage>
  <submitdate>10/09/2012</submitdate>
  <approvaldate>8/10/2012</approvaldate>
  <actrnumber>ACTRN12612001075875</actrnumber>
  <trial_identification>
    <studytitle>The effect of clonidine on heart rate variability analysis in patients undergoing key-hole surgery to remove gallbladder</studytitle>
    <scientifictitle>A prospective study to validate the effect of clonidine on Analgesia Nociceptive Index in patients undergoing laparoscopic cholecystectomy</scientifictitle>
    <utrn>U1111-1134-4651</utrn>
    <trialacronym />
    <secondaryid>NIL</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Intraoperative pain relief during cholecystectomy</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients will receive a standardised protocol for induction of anaesthesia with fentanyl, propofol and rocuronium. . A standard IV paracetamol 1g and IV Parecoxib 40mg (if no contraindication) are also given. Analgesia Nociception Index (ANI) will be recorded at every 5 minute intervals. IV Clonidine 1mcg/kg will be given 5 mins following pneumoperitoneum. Any further dose of fentanyl given will be recorded</interventions>
    <comparator>the patient acts as his own control whereby the ANI of pre-clonidine is compared against post clonidine</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Effect of clonidine on ANI, whether it increases, decreases or no change; a mean 10 point change being accepted as significant</outcome>
      <timepoint>ANI, BP and HR recorded pre surgical incison, at surgical incison, pre carbon dioxide insufflation into peritoneum, 5 minutes after CO2 insufflation when clonidine is given, and every 5 minutes thereafter for 30 minutes

total about 60 minutes</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>NIL</outcome>
      <timepoint>NIL</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Laparoscopic cholecystectomy</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>unable to consent
below 18 years old
Established arrhythmias
Allergy/sensitivity to clonidine
diabetes mellitus and autonomic neuropathy
sepsis/ emodynamic instability
chronic pain</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Patients who fulfill the inclusion and exclusion criteria will be identified from the surgical operating list (emergency and elective). Informed written consent will be obtained by the research team or the anaesthetist/anaestetic registrar. There is no randomization involved.</concealment>
    <sequence>NIL</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures>NIL</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>17/09/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>44</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>fremantle Hospital</primarysponsorname>
    <primarysponsoraddress>Alma Street
Fremantle
WA 6160</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Fremantle Hospital</fundingname>
      <fundingaddress>Alma Street
Fremantle
WA 6160</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Clonidine has been effectively used as a non-opioid (morphine-like) pain killer and sedative in a variety of clinical settings for many years. The Analgesia Nociceptive Index (ANI) monitor is a novel anaesthetic monitor that has been developed for use with opioid based pain killers. It works by assessing (primarily) heart rate variability to generate a score which gives an indication of nociceptive (painful) inputs. This study aims to examine the effects of clonidine on the ANI under general anaesthesia for laparoscopic cholecystectomy, as part of the pain relieving strategy</summary>
    <trialwebsite>NIL</trialwebsite>
    <publication>NIL</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee, Fremantle Hospital</ethicname>
      <ethicaddress>Fremantle Hospital and Health Service
Alma Street
fremantle
WA 6160</ethicaddress>
      <ethicapprovaldate />
      <hrec>1/12/0244</hrec>
      <ethicsubmitdate>7/08/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Anisa Abu Baker</name>
      <address>Department of Anaesthetics
Fremantle Hospital and Health Service
Alma Street
Fremantle
Western Australia 6160</address>
      <phone>+61894312551</phone>
      <fax>+61894312171</fax>
      <email>anisa.aisha@gmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anisa Abu Baker</name>
      <address>Department of Anaesthetics
Fremantle Hospital and Health Service
Alma Street
Fremantle
Western Australia 6160</address>
      <phone>+61894312551</phone>
      <fax>+61894312171</fax>
      <email>anisa.aisha@gmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anisa Abu Baker</name>
      <address>Fremantle Hospital and Health Service
Alma Street
Fremantle
Western Australia 6160</address>
      <phone>+61894312551</phone>
      <fax>+61894312171</fax>
      <email>anisa.aisha@gmail.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>